Search bioRxiv⌕ Search

Biology subjects

Mulholland, A.

Publications and source records attributed to Mulholland, A..

2 recordsLinked to original sources

Four additional natural 7-deazaguanine derivatives in phages and how to make them

Bacteriophages and bacteria are engaged in a constant arms race, continually evolving new molecular tools to survive one another. To protect their genomic DNA from restriction enzymes, the most common bacterial defence systems, double-stranded DNA phages have evolved complex modifications that affect all four bases. This study focuses on modifications at position 7 of guanines. Eight derivatives of 7-deazaguanines were identified, including four previously unknown ones: 2-deoxy-7-(methylamino)methyl-7-deazaguanine (mdPreQ1), 2-deoxy-7-(formylamino)methyl-7-deazaguanine (fdPreQ1), 2-deoxy-7-deazaguanine (dDG), and 2-deoxy-7-carboxy-7-deazaguanine (dCDG). These modifications are inserted in DNA by a guanine transglycosylase named DpdA. Three subfamilies of DpdA had been previously characterized: bDpdA, DpdA1, and DpdA2. Two additional subfamilies were identified in this work: DpdA3, which allows for complete replacement of the guanines, and DpdA4, which is specific to archaeal viruses. Transglycosylases have now been identified in all phages and viruses carrying 7-deazaguanine modifications, indicating that the insertion of these modifications is a post-replication event. Three enzymes were predicted to be involved in the biosynthesis of these newly identified DNA modifications: 7-carboxy-7-deazaguanine decarboxylase (DpdL), dPreQ1 formyltransferase (DpdN), and dPreQ1 methyltransferase (DpdM), which was experimentally validated and harbors a unique fold not previously observed for nucleic acid methylases.

genomics↗

A modified Rayleigh-Plesset equation for a liquid-crystalline shelled microbubble

Premanufactured shelled microbubbles composed of a protein shell are currently licensed as ultrasound imaging contrast agents. Current research is focussing on using the protein shelled microbubbles as transportation mechanisms for localised drug delivery particularly in the treatment of various types of cancer. For the very first time, a theoretical model is developed for an incompressible, gas loaded shelled microbubble with a thin shell composed of a liquid-crystalline material. We show that liquid-crystalline shelled microbubbles exhibit significantly different physical characteristics from commercial protein shelled microbubbles such as Sonovue and Optison. The authors propose that these significantly different physical characteristics may enhance localised drug delivery. We use the technique of linearisation to predict the shelled microbubbles natural frequency and relaxation time. These physical parameters strongly influence sonoporation which is the mechanism that is used for localised drug delivery. The influence of the material properties of the shell on the natural frequency and relaxation time are discussed. We have discovered that liquid-crystalline shelled microbubbles have a relaxation time that is 10 times longer than Sonovue and Optison.

bioengineering↗